Worldwide Study Finder

Not applicableUnknownINTERVENTIONAL

Carbetocin Versus Oxytocin for Prophylaxis Against Atonic Primary Post-partum Hemorrhage

ClinicalTrials.gov · NCT05479357 · Registry updated: 2022-08-02

Condition / research focus: Atonic Postpartum Hemorrhage; High Risk Pregnancy
Sponsor: Sohag University
Countries with listed sites: No country reported
Registry dates and results: Start: 2022-07-28. Completion: 2022-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Carbetocin (drug)

Where the study takes place — 0 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome

ClinicalTrials.gov · NCT03649477 · Registry updated: 2022-07-26

Condition / research focus: Prader-Willi Syndrome
Sponsor: Levo Therapeutics, Inc.
Countries with listed sites: Australia · Canada · United States
Registry dates and results: Start: 2018-11-20. Completion: 2022-07-09 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

3.2 mg intranasal carbetocin (drug) — also listed as: LV-101
9.6 mg intranasal carbetocin (drug) — also listed as: LV-101
placebo (drug)

Where the study takes place — 24 listed sites

University of Alabama at Birmingham
Birmingham, Alabama, United States
Site recruitment: Not reported
Phoenix Children's Hospital
Phoenix, Arizona, United States
Site recruitment: Not reported
Children's Hospital of Los Angeles (USC)
Los Angeles, California, United States
Site recruitment: Not reported
Rady Children's Hospital San Diego
San Diego, California, United States
Site recruitment: Not reported
Children's Hospital Colorado
Aurora, Colorado, United States
Site recruitment: Not reported
Children's National
Washington D.C., District of Columbia, United States
Site recruitment: Not reported
University of Florida
Gainesville, Florida, United States
Site recruitment: Not reported
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Site recruitment: Not reported
Kansas University Medical Center
Kansas City, Kansas, United States
Site recruitment: Not reported
University of Harvard Boston Children's Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported
Children's Hospitals and Clinics of Minnesota
Saint Paul, Minnesota, United States
Site recruitment: Not reported
Cardinal Glennon Children's Medical Center
St Louis, Missouri, United States
Site recruitment: Not reported
Nationwide Children's Hospital
Columbus, Ohio, United States
Site recruitment: Not reported
University of Oklahoma Health Sciences Center
Tulsa, Oklahoma, United States
Site recruitment: Not reported
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Vanderbilt University School of Medicine
Nashville, Tennessee, United States
Site recruitment: Not reported
Texas Children's Hospital
Houston, Texas, United States
Site recruitment: Not reported
Children's Hospital of San Antonio
San Antonio, Texas, United States
Site recruitment: Not reported
University of Utah
Salt Lake City, Utah, United States
Site recruitment: Not reported
Queensland Children's Hospital
South Brisbane, Queensland, Australia
Site recruitment: Not reported
University of Alberta
Edmonton, Alberta, Canada
Site recruitment: Not reported
British Columbia Children's Hospital
Vancouver, British Columbia, Canada
Site recruitment: Not reported
Toronto Hospital for Sick Kids
Toronto, Ontario, Canada
Site recruitment: Not reported
CHU Ste Justine
Montreal, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

EMG for Uterotonic Efficiency Estimation

ClinicalTrials.gov · NCT04201665 · Registry updated: 2022-06-27

Condition / research focus: Postpartum Hemorrhage
Sponsor: University Medical Centre Ljubljana
Countries with listed sites: Slovenia
Registry dates and results: Start: 2020-09-13. Completion: 2022-01-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)

Where the study takes place — 1 listed sites

UMC Ljubljana
Ljubljana, Slovenia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy

ClinicalTrials.gov · NCT04482959 · Registry updated: 2022-04-06

Condition / research focus: Myoma;Uterus
Sponsor: Mansoura University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2020-07-15. Completion: 2022-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Sodium chloride 0.9% (drug)

Where the study takes place — 1 listed sites

Faculty of Medicine
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets

ClinicalTrials.gov · NCT05266534 · Registry updated: 2022-03-04

Condition / research focus: Myoma
Sponsor: Wael Elbanna Clinic
Countries with listed sites: Egypt
Registry dates and results: Start: 2021-12-30. Completion: 2026-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: glypressin
Carbetocin (drug) — also listed as: pabal
Saline (drug) — also listed as: NaCl 0.9

Where the study takes place — 1 listed sites

Wael El Banna Clinic
Maadi, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetocin During C-section

ClinicalTrials.gov · NCT05083910 · Registry updated: 2022-01-25

Condition / research focus: Postpartum Hemorrhage
Sponsor: Bezmialem Vakif University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2021-07-01. Completion: 2022-01-22 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

I.V Oxytocin administration (drug) — also listed as: I.v Oxytocin+intrauterine misoprostol, I.V carbetocin administration

Where the study takes place — 2 listed sites

Bezmialem Vakif University
Istanbul, Istanbulk, Turkey (Türkiye)
Site recruitment: Not reported
Bezmialem Vakif University
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Protocols for Prevention of PPH During CS in High Risk Group

ClinicalTrials.gov · NCT05099575 · Registry updated: 2021-10-29

Condition / research focus: Atonic PPH
Sponsor: Assiut University
Countries with listed sites: No country reported
Registry dates and results: Start: 2021-10-30. Completion: 2022-10-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon, papal, misotac (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Impact of Carbetocin Administration on Heart Rate When Given as an Infusion Versus as a Bolus.

ClinicalTrials.gov · NCT03404544 · Registry updated: 2021-10-04

Condition / research focus: Cesarean Section Complications; Hemodynamic Instability
Sponsor: Ciusss de L'Est de l'Île de Montréal
Countries with listed sites: Canada
Registry dates and results: Start: 2018-06-11. Completion: 2021-01-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin bolus (drug) — also listed as: Duratocin
Carbetocin infusion (drug) — also listed as: Duratocin

Where the study takes place — 1 listed sites

CIUSSS de l'Est de l'Ile de Montreal
Montreal, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage

ClinicalTrials.gov · NCT03870256 · Registry updated: 2021-09-29

Condition / research focus: Post Partum Hemorrhage
Sponsor: Aswan University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-04-01. Completion: 2021-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

misoprostol (drug) — also listed as: Active comparator
Carbetocin (drug) — also listed as: Active Comparator
TA (drug) — also listed as: Active Comparator

Where the study takes place — 1 listed sites

AswanUH
Aswān, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage

ClinicalTrials.gov · NCT03870503 · Registry updated: 2021-09-29

Condition / research focus: Postpartum Hemorrhage
Sponsor: Aswan University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-04-01. Completion: 2021-08-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: Active comparator
oxytocin plus misoprostol (drug) — also listed as: Active Comparator
Carbetocin (drug) — also listed as: Active Comparator

Where the study takes place — 1 listed sites

Aswan University Hospital
Aswān, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section

ClinicalTrials.gov · NCT02044549 · Registry updated: 2021-06-24

Condition / research focus: Postpartum Hemorrhage; Blood Loss
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-06. Completion: 2015-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

carbetocin (drug) — also listed as: Pabal
Syntometrine (drug) — also listed as: Oxytocin methergine combination

Where the study takes place — 1 listed sites

Ahmed Maged
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

The Clinical Carbetocin Myocardium Trial

ClinicalTrials.gov · NCT02528136 · Registry updated: 2021-06-14

Condition / research focus: Pregnancy
Sponsor: Oslo University Hospital
Countries with listed sites: Norway
Registry dates and results: Start: 2015-09. Completion: 2019-01-28 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
Oxytocin (drug) — also listed as: Syntocinon

Where the study takes place — 1 listed sites

Oslo University Hospital, Division of Emergencies and Critical Care
Oslo, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study

ClinicalTrials.gov · NCT03716076 · Registry updated: 2021-05-14

Condition / research focus: Cardiac Arrythmias
Sponsor: University of British Columbia
Countries with listed sites: Canada
Registry dates and results: Start: 2018-11-01. Completion: 2020-04-24 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)

Where the study takes place — 1 listed sites

BC Women's Hospital
Vancouver, British Columbia, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Carbetocin vs. Oxytocin at Elective Cesarean Section

ClinicalTrials.gov · NCT03168698 · Registry updated: 2021-03-03

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2017-05-25. Completion: 2020-12-18 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin
Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 2 listed sites

McMaster University Medical Centre (MUMC)
Hamilton, Ontario, Canada
Site recruitment: Not reported
Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Uterotonics for Severe Preeclampsia

ClinicalTrials.gov · NCT04756661 · Registry updated: 2021-02-16

Condition / research focus: Preeclampsia Severe
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2020-01-01. Completion: 2021-02-10 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)
Misoprostol (drug)

Where the study takes place — 1 listed sites

Assiut Faculty of Medicine
Asyut, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Carbetocin Versus Misoprostol in Cases With Placenta Previa After C.S.

ClinicalTrials.gov · NCT02277041 · Registry updated: 2021-02-02

Condition / research focus: Postpartum Hemorrhage
Sponsor: Beni-Suef University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-10. Completion: 2021-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
Misoprostol (drug) — also listed as: Misotac

Where the study takes place — 1 listed sites

Beni-Suef University
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.

ClinicalTrials.gov · NCT02277067 · Registry updated: 2021-02-02

Condition / research focus: Postpartum Hemorrhage
Sponsor: Beni-Suef University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-10. Completion: 2021-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
Misoprostol (drug) — also listed as: Misotac

Where the study takes place — 1 listed sites

Beni-Suef University
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Methods to Reduce Blood Loss in Abdominal Myomectomy

ClinicalTrials.gov · NCT04595812 · Registry updated: 2020-10-22

Condition / research focus: Abdominal Myomectomy; Blood Loss
Sponsor: Cairo University
Countries with listed sites: No country reported
Registry dates and results: Start: 2020-11-01. Completion: 2022-09-15 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol 200mcg Tab vaginal (drug) — also listed as: cytotec
Oxytocin (drug)
Carbetocin (drug) — also listed as: Pabal, Ferring (UK)
pericervical hemostatic tourniquet (procedure)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Carbetocin Versus Buccal Misoprostol Plus IV Tranexamic Acid for Prevention of Postpartum Hemorrhage at Cesarean Section

ClinicalTrials.gov · NCT03710317 · Registry updated: 2020-08-05

Condition / research focus: Cesarean Section Complications
Sponsor: Aswan University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-12-01. Completion: 2020-08-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

carbetocin (drug) — also listed as: Active Comparator
Tranexamic Acid (drug) — also listed as: Experimental
misoprostol (drug) — also listed as: expremental

Where the study takes place — 1 listed sites

Aswan University
Aswān, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery

ClinicalTrials.gov · NCT03708497 · Registry updated: 2020-08-05

Condition / research focus: Postpartum Hemorrhage
Sponsor: Aswan University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-12-01. Completion: 2020-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

carbetocin (drug) — also listed as: Active Comparator
Tranexamic acid plus misoprostol (drug) — also listed as: active comparator
misoprostol (drug) — also listed as: active comparator

Where the study takes place — 2 listed sites

Aswan University
Aswān, Egypt
Site recruitment: Not reported
AswanUH
Aswān, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Worldwide Study Finder

Find a study

Registry search results

Carbetocin Versus Oxytocin for Prophylaxis Against Atonic Primary Post-partum Hemorrhage

Explore the world’s study registries

Worldwide

Africa

Americas

Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome

EMG for Uterotonic Efficiency Estimation

Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets

Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetocin During C-section

Protocols for Prevention of PPH During CS in High Risk Group

Impact of Carbetocin Administration on Heart Rate When Given as an Infusion Versus as a Bolus.

Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage

Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage

Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section

The Clinical Carbetocin Myocardium Trial

Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study

Carbetocin vs. Oxytocin at Elective Cesarean Section

Uterotonics for Severe Preeclampsia

Carbetocin Versus Misoprostol in Cases With Placenta Previa After C.S.

Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.

Methods to Reduce Blood Loss in Abdominal Myomectomy

Carbetocin Versus Buccal Misoprostol Plus IV Tranexamic Acid for Prevention of Postpartum Hemorrhage at Cesarean Section

Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery

Asia

Middle East

Europe

Oceania